Survival Curve from Scientific Research

Survival comparison of all evaluable rGBM patients with either negative/low (1, 2) or intermediate/high (3, 4) tumor CD3 IHC scores. Dashed lines depict medians in months (Mo). Median survival times with 95% CIs in parentheses are also indicated; NA means infinity. P values comparing survival distribution of each group using the two-sided peto-peto test are depicted.

DOI